Clinical evolution. (A) Kaplan-Meier survival curve of GATA2-mutated patients. Confidence intervals of 95% are indicated. (B) Evolution of GATA2-mutated patients to MDS or AML from birth to evolution to MDS or AML or last follow-up. Confidence intervals of 95% are indicated.